Funder
Commission of the European Communities, Seventh Framework Programme
Advanced Immunization Technologies
Horizon 2020 Framework Programme
Fondazione Cassa di Risparmio delle Province Lombarde
Ministry of Education and Science of the Russian Federation
Subject
Immunology,Immunology and Allergy
Cited by
303 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Analysis of health claims data on vaccination coverage in older adults in Bavaria, Germany: Influenza, pneumococcus and herpes zoster;Vaccine;2024-12
2. A phase 2, randomized, blinded, dose-finding, controlled clinical trial to evaluate the safety, tolerability, and immunogenicity of a 24-valent pneumococcal conjugate vaccine (VAX-24) in healthy adults 65 years and older;Vaccine;2024-11
3. An in-depth understanding of the role and mechanisms of T cells in immune organ aging and age-related diseases;Science China Life Sciences;2024-09-02
4. Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B);International Journal of Infectious Diseases;2024-09
5. Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: A French nationwide multicenter cohort study—ANRS0001s COV-POPART;International Journal of Infectious Diseases;2024-09